As of Q3 2020, the wholesale acquisition cost of autoimmune disease drug Remicade was around 1,168 U.S. dollars, compared to 946 U.S. dollars for the biosimilar Inflectra. Biosmilars of Remicade were able to reduce costs between 19 and 59 percent. This statistic illustrates a comparison WAC of Remicade vs biosimilars in the United States.
Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q3 2020
(in U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Amgen. (October 31, 2022). Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q3 2020 (in U.S. dollars) [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Amgen. "Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q3 2020 (in U.S. dollars)." Chart. October 31, 2022. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Amgen. (2022). Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q3 2020 (in U.S. dollars). Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Amgen. "Comparison of The Wholesale Acquisition Cost (Wac) of Remicade Vs Biosimilars in The United States as of Q3 2020 (in U.S. Dollars)." Statista, Statista Inc., 31 Oct 2022, https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Amgen, Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q3 2020 (in U.S. dollars) Statista, https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/ (last visited November 21, 2024)
Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q3 2020 (in U.S. dollars) [Graph], Amgen, October 31, 2022. [Online]. Available: https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
